Limited Competition: IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed)

The summary for the Limited Competition: IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition: IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed): The purpose of this Funding Opportunity Announcement (FOA) is to provide opportunities for eligible U.S. small business concerns (SBCs), together with academic partners, in the Northeast region of the Institutional Development Award (IDeA)-eligible states, to apply forIDeA Regional Entrepreneurship Development (I-RED) program awards that support the development of educational products to promote biomedical entrepreneurship in the Northeast region of IDeA states. These educational products are expected to address the needs of IDeA state academic institutions in developing and/or strengthening technology transfer programs that stimulate technological innovation by translating scientific discoveries and technologies from research laboratories into commercial products that improve human health and promote economic growth in the Northeast region of IDeA states.
Federal Grant Title: Limited Competition: IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-22-254
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.859
CFDA Descriptions: Information not provided
Current Application Deadline: January 6th, 2023
Original Application Deadline: January 6th, 2023
Posted Date: September 16th, 2022
Creation Date: September 16th, 2022
Archive Date: February 11th, 2023
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: September 16th, 2022
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Link to Full Grant Announcement
https://grants.nih.gov/grants/guide/pa-files/PAR-22-254.html
Grant Announcement Contact
NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants
Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial N...
Maximizing Investigators' Research Award (MIRA) for Early Stage Investigators (ESI)
National Centers for Cryo-electron Tomography (cryoET) (R24 -Clinical Trial Not Allowed)
NIGMS Institutional Biomedical Undergraduate Research Training (BURT) Program (T34)
Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional)
Tools for Genetic and Genomic Studies in Emerging Model Organisms
Evolution of Infectious Diseases
Mbrs Support of Continuous Research Excellence (Score)
More Grants from the National Institutes of Health
HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development (HBCD) St...
HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development Study - R...
Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on H...
NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clini...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2026 FederalGrants.com